Israeli study: Under $1 parasitic drug helps Kovid infection go away in a matter of days
According to the research conducted by Sheba Medical Center, Ivermectin, which is used in the fight against parasites in 3rd World countries, reduces the duration of the disease and the level of contagiousness in people exposed to coronavirus, while its cost comes to less than 1 dollar a day.
The anti-parasitic pill called Ivermectin, which was claimed to be 'the drug that kills the coronavirus in 2 days' in the first wave of the pandemic last year, is on the agenda again.
According to the research conducted by the Sheba Medical Center, which deals with tropical diseases and medicines needed during travel in Israel, Ivermectin, which is used in the fight against parasites in 3rd World countries, reduces the duration of the disease and the level of contagiousness in people exposed to the coronavirus, while its cost is less than $ 1 a day.
Nobel prize medicine
The creators of the drug, which was approved by the US Food and Drug Administration (FDA) in 1987, were awarded the 2015 Nobel Prize in Medicine for finding a cure for onchocerciasis, or river blindness, caused by a parasitic roundworm infection.
From parasites to viruses
Ivermectin, which has been used against parasites such as head lice and scabies for years, has also been effective against a number of viruses from influenza to HIV, from Zika to West Nile in clinical trials in the last 10 years.
The cost of 5-day treatments with Ivermectin, an extremely economical drug, in Bangladesh ranges from 0.60-1.80 dollars.
72 percent of those who ingested ivermectin test negative
Professor in Israel In a double-blind experiment conducted by Sheba Medical Center, founded by Eli Schwartz, with 89 adult volunteers with low and moderate Kovid-19 who did not require hospitalization between May 15, 2020 and January 31, 2021, subjects who swallowed the pill an hour before a meal for three days, three days after stopping the pill, that is, on the sixth day, he was tested. Of those given ivermectin, 72 percent tested negative, and only 13 percent remained contagious.
'It would have a huge socio-economic impact'
Stating that the research published in MedRxiv first of all shows that Ivermectin has antiviral activity, Schwartz said that the probability of the person using the drug to get rid of the infection within 4-6 days is almost 100 percent. "This could have a huge economic and social impact, as it could lead to a shorter isolation period for people," he said.
FDA and WHO do not approve use against Kovid
In a study previously published in the American Journal of Therapeutics, it was mentioned that Ivermectin, which showed strong treatment effectiveness against Kovid, reduced Kovid deaths by 75 percent.
Despite such findings, neither the FDA nor the UN-affiliated World Health Organization (WHO) are willing to approve the use of Ivermectin in the fight against coronavirus.